ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

XENE Xenon Pharmaceuticals Inc

40.50
0.40 (1.00%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Xenon Pharmaceuticals Inc XENE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.40 1.00% 40.50 17:30:00
Open Price Low Price High Price Close Price Prev Close
40.02 39.80 40.87 40.50 40.10
more quote information »

Recent News

Date Time Source Heading
4/16/202408:30GLOBEXenon Pharmaceuticals Showcases XEN1101 at the American..
4/04/202416:01GLOBEXenon Pharmaceuticals to Present at the 23rd Annual Needham..
3/12/202416:01GLOBEXenon Pharmaceuticals to Present at Stifel 2024 Virtual CNS..
3/08/202418:47EDGAR2Form 144 - Report of proposed sale of securities
3/08/202417:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202417:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/08/202417:27EDGAR2Form 8-K - Current report
3/07/202419:04EDGAR2Form 144 - Report of proposed sale of securities
3/07/202419:03EDGAR2Form 144 - Report of proposed sale of securities
3/05/202416:01GLOBEXenon Pharmaceuticals to Present at Leerink Partners Global..
2/29/202416:10EDGAR2Form 8-K - Current report
2/29/202416:01GLOBEXenon Pharmaceuticals Reports Fourth Quarter and Full Year..
2/22/202416:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
2/14/202409:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
1/08/202408:00GLOBEXenon Pharmaceuticals Outlines Key Milestone Opportunities..
1/03/202408:30GLOBEXenon Pharmaceuticals to Present at the 42nd Annual J.P...
1/02/202416:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/04/202316:16GLOBEXenon Pharmaceuticals Announces Closing of $345.0 Million..
12/02/202312:01GLOBEXenon Pharmaceuticals Provides Updates on Neurology Pipeline..
11/30/202316:18EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/30/202316:15EDGAR2Form 8-K - Current report
11/29/202322:51GLOBEXenon Pharmaceuticals Announces Pricing of Upsized $300.0..
11/29/202317:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/29/202316:03GLOBEXenon Pharmaceuticals Announces Proposed Public Offering
11/27/202307:03EDGAR2Form 8-K - Current report
11/27/202307:00GLOBEXenon Pharmaceuticals Announces Topline Results from Phase 2..
11/09/202316:06EDGAR2Form 8-K - Current report
11/09/202316:03GLOBEXenon Pharmaceuticals Provides Update on Partnered Program..
11/08/202316:36EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/202316:11EDGAR2Form 8-K - Current report
11/08/202316:01GLOBEXenon Pharmaceuticals Reports Third Quarter 2023 Financial..
11/01/202316:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
10/09/202316:15GLOBEXenon Pharmaceuticals Announces Publication of Results from..
10/06/202308:30GLOBEXenon Pharmaceuticals to Present at Jefferies Inaugural..
9/14/202316:01GLOBEXenon Pharmaceuticals to Present at TD Cowen’s 3rd Annual..
9/12/202316:30GLOBEXenon Pharmaceuticals Announces Upcoming Investor Webinar..
9/04/202308:30GLOBEXenon Pharmaceuticals Showcases XEN1101 Epilepsy Program at..
8/31/202316:01GLOBEXenon Pharmaceuticals to Present at the Wells Fargo 2023..
8/10/202319:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202319:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/10/202318:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
8/10/202318:40EDGAR2Form 3 - Initial statement of beneficial ownership of..
8/09/202316:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/09/202316:16EDGAR2Form 8-K - Current report
8/09/202316:01GLOBEXenon Pharmaceuticals Reports Second Quarter 2023 Financial..
8/08/202316:07EDGAR2Form 8-K - Current report
8/08/202316:01GLOBEXenon Pharmaceuticals Expands Leadership on its Board of..
8/02/202316:01GLOBEXenon Pharmaceuticals Announces Conference Call and Webcast..
6/06/202316:35GLOBEXenon Pharmaceuticals to Present at the Goldman Sachs 44th..
5/31/202316:01GLOBEXenon Pharmaceuticals to Present at the 2023 Jefferies..

Your Recent History

Delayed Upgrade Clock